GCP
GSA Capital Partners Portfolio holdings
AUM
$1.43B
1-Year Return
20.34%
This Quarter Return
-4.34%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$1.17B
AUM Growth
+$167M
(+17%)
Cap. Flow
+$200M
Cap. Flow
% of AUM
17.11%
Top 10 Holdings %
Top 10 Hldgs %
3.75%
Holding
2,064
New
608
Increased
491
Reduced
336
Closed
627
Top Buys
| 1 |
Teck Resources
TECK
|
+$4.06M |
| 2 |
Constellation Brands
STZ
|
+$3.83M |
| 3 |
Revolve Group
RVLV
|
+$3.82M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$3.7M |
| 5 |
NVIDIA
NVDA
|
+$3.67M |
Top Sells
| 1 |
e.l.f. Beauty
ELF
|
+$4.49M |
| 2 |
Copa Holdings
CPA
|
+$3.78M |
| 3 |
Cardlytics
CDLX
|
+$3.54M |
| 4 |
Idexx Laboratories
IDXX
|
+$2.94M |
| 5 |
Sonos
SONO
|
+$2.61M |
Sector Composition
| 1 | Healthcare | 14.25% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Technology | 13.74% |
| 4 | Financials | 11.52% |
| 5 | Industrials | 11.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Alaunos Therapeutics
TCRT
$5.25M
| $75K | 0.01% |
3,797
-6,082
| -62% | -$120K |
|
|
KRON
1402
DELISTED
Kronos Bio
KRON
| $71K | 0.01% |
54,521
-231,644
| -81% | -$302K |
|
|
RENT
1403
Rent the Runway
RENT
$32.3M
| $71K | 0.01% |
5,239
-12,550
| -71% | -$170K |
|
1404
Sight Sciences
SGHT
$190M
| $69K | 0.01% |
20,386
-242
| -1% | -$819 |
|
1405
McEwen Inc.
MUX
$747M
| $67K | 0.01% |
+10,251
| New | +$67K |
|
|
DHC
1406
Diversified Healthcare Trust
DHC
$1.09B
| $65K | 0.01% |
33,567
-376,523
| -92% | -$729K |
|
1407
Epsilon Energy
EPSN
$122M
| $65K | 0.01% |
+12,229
| New | +$65K |
|
1408
Delcath Systems
DCTH
$389M
| $63K | 0.01% |
+15,590
| New | +$63K |
|
|
DNMR
1409
DELISTED
Danimer Scientific, Inc.
DNMR
| $63K | 0.01% |
764
+358
| +88% | +$29.5K |
|
|
NUTX
1410
Nutex Health
NUTX
$511M
| $62K | 0.01% |
+2,025
| New | +$62K |
|
|
ASXC
1411
DELISTED
Asensus Surgical, Inc.
ASXC
| $61K | 0.01% |
225,538
-675,670
| -75% | -$183K |
|
1412
Outlook Therapeutics
OTLK
$48.4M
| $57K | ﹤0.01% |
+12,970
| New | +$57K |
|
1413
Praxis Precision Medicines
PRAX
$830M
| $57K | ﹤0.01% |
2,237
+1,417
| +173% | +$36.1K |
|
1414
Altisource Portfolio Solutions
ASPS
$124M
| $53K | ﹤0.01% |
+1,659
| New | +$53K |
|
1415
Caribou Biosciences
CRBU
$178M
| $51K | ﹤0.01% |
+10,734
| New | +$51K |
|
1416
Lyell Immunopharma
LYEL
$256M
| $51K | ﹤0.01% |
+1,727
| New | +$51K |
|
1417
Sabre
SABR
$742M
| $51K | ﹤0.01% |
+11,358
| New | +$51K |
|
1418
Byrna Technologies
BYRN
$461M
| $50K | ﹤0.01% |
22,229
-93,257
| -81% | -$210K |
|
1419
Abeona Therapeutics
ABEO
$346M
| $49K | ﹤0.01% |
+11,638
| New | +$49K |
|
1420
Rackspace Technology
RXT
$357M
| $49K | ﹤0.01% |
+20,855
| New | +$49K |
|
1421
Clean Energy Fuels
CLNE
$555M
| $48K | ﹤0.01% |
+12,573
| New | +$48K |
|
|
IRD
1422
Opus Genetics, Inc. Common Stock
IRD
$84.5M
| $46K | ﹤0.01% |
+13,588
| New | +$46K |
|
|
ATYR
1423
aTyr Pharma
ATYR
$515M
| $44K | ﹤0.01% |
+27,559
| New | +$44K |
|
|
AMRN
1424
Amarin Corp
AMRN
$310M
| $42K | ﹤0.01% |
2,284
-2,234
| -49% | -$41.1K |
|
1425
Companhia Siderúrgica Nacional
SID
$1.99B
| $42K | ﹤0.01% |
+17,380
| New | +$42K |
|